| |
July 22, 2011
Elekta European Users’ Conference Attracts Top Minds in Cancer Management
|
|
Elekta users from Europe, Asia, the Middle East, North America and Africa converged on Hotel Hohe Düne in Warnemünde, Germany June 16-19 to participate in Elekta’s fifth European Users’ Conference. Approximately 390 clinicians and scientists attended 31 presentations and workshops given by Elekta users and company representatives on a wide range of cancer management topics. The Users’ Conference was preceded by the Elekta Stereotactic Users’ Meeting, June 15-16 |
|
Read More ...
|
|
| |
May 24, 2011
Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting
|
|
For the fifth straight year, Elekta has been selected to demonstrate at the American Society of Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June 4-6, at McCormick Place in Chicago. In the spotlight will be Elekta’s MOSAIQ® Oncology Information System, the first and only oncology-specific comprehensive EMR certified for Meaningful Use under the federal government’s HITECH Act. MOSAIQ is fully prepared for centers planning attestation in 2011 or 2012. |
|
Read More ...
|
|
| |
March 28, 2011
Elekta Releases MOSAIQ Oncology Information System Interface to Xstrahl Treatment Units
|
|
Elekta’s MOSAIQ® version 2.20 now includes an interface to Xstrahl’s superficial and orthovoltage radiotherapy systems, enabling users of these therapy machines to prepare, deliver and record treatments via MOSAIQ. The Xstrahl family of treatment systems treats superficial tumors and benign lesions (e.g., basal cell and squamous cell carcinomas, keloid scars and dermatological conditions) with low-energy radiation. |
|
Read More ...
|
|
| |
December 2, 2010
Elekta to Highlight Next Generation MEG System for Studying Brain Activity at American Epilepsy Society Meeting
|
|
At the American Epilepsy Society’s 64th Annual Meeting, December 3-7 in San Antonio, Elekta will demonstrate its latest generation magnetoencephalography (MEG) platform for investigating human brain activity, particularly in patients with epilepsy. Raising functional mapping to the next level, Elekta Neuromag® TRIUX* addresses key MEG requirements that are critical for robust functional mapping studies. Benefits of the system include higher tolerance for magnetic interferences, new user interface features and patient comfort enhancements. |
|
Read More ...
|
|
| |
November 2, 2010
Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology
|
|
Elekta’s MOSAIQ® Oncology PACS has evolved to a new level with MOSAIQ Data Director, an image and data management solution for oncology professionals that enables them to direct the interchange of images and information and address the requirements of the modern oncology workflow. Fully integrated with the MOSAIQ Oncology Information System (OIS), MOSAIQ Data Director transforms the patient chart into the centralized control point to manage, view, move and archive patient images and data. Users can harness the new Web-based viewer to explore data and archived images or objects online using powerful 3D functionality. |
|
Read More ...
|
|
| |
December 29, 2009
Elekta wins World Class Manufacturing Award
|
|
Elekta, the world-leading manufacturer of treatment solutions for cancer and brain disorders, has been awarded the prestigious World Class Manufacturing award by The Manufacturer magazine. The World Class Manufacturing award was given in recognition of the quality work produced each year by Elekta manufacturing staff. |
|
Read More ...
|
|
| |
November 24, 2009
Elekta Compact brings Radiation Therapy to patients in India
|
|
The Indo-American Cancer Institute and Research Center is the first in India to treat cancer patients with Elekta Compact™, Elekta’s robust, cost-effective linear accelerator for radiation therapy that addresses the cancer care needs of a wider population. The first patient treated on the system was a 52-year-old woman with breast cancer. |
|
Read More ...
|
|
| |
November 2, 2009
Elekta presents new Image-Guidance Solutions at Capital Markets Day in Chicago, USA
|
|
At Elekta’s Capital Markets Day held in connection to the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Chicago, USA, Elekta presented new tools for improved clinical precision, workflow efficiency and patient comfort. Highlights included Intuity™*and Symmetry™* advanced image-guidance solutions that build upon the company’s existing expertise. |
|
Read More ...
|
|
| |
September 9, 2009
Hitachi selects software solutions from Elekta for Proton Therapy Center in Japan
|
|
Hitachi has selected Elekta to provide workflow enhancing software for its PROBEAT® proton therapy facility at West Medical Center in Nagoya, Japan. Enabling the facility to manage patient data in a chartless, paperless environment, the facility is the second Hitachi-equipped center to implement MOSAIQ®, Elekta’s oncology information system (OIS) for cancer care. |
|
Read More ...
|
|
| |
September 3, 2009
Elekta Technology At Work In 94 Percent Of America's Top Cancer Hospitals
|
|
U.S. News & World Report recently issued its annual list of America’s best hospitals and 94 percent of the top cancer hospitals in the country are users of Elekta solutions. For patients throughout the U.S., this means the vast majority of the best cancer treatment facilities also have the best information management, treatment planning and delivery systems available. |
|
Read More ...
|
|
| |
July 14, 2009
Juntendo University begins VMAT treatments for Prostate Cancer
|
|
On April 13, Juntendo University (Tokyo, Japan) became the third facility in Japan to begin using Elekta Synergy® to treat prostate patients with Volumetric Modulated Arc Therapy (VMAT). Using VMAT, treatment times can be dramatically shorter and treatment margins are much more conformal than with conventional IMRT. And VMAT requires significantly fewer MUs than conventional IMRT, reducing total MU delivery by up to 50 percent. |
|
Read More ...
|
|
| |
June 26, 2009
First Elekta VMAT Facility in Japan Approaches One-Year Milestone
|
|
University of Tokyo Hospital has been treating patients for nearly one year with Elekta Volumetric Modulated Arc Therapy (VMAT). The hospital was the first facility in Japan to use this revolutionary cancer-fighting tool, which can shorten radiation treatment times and provide state-of-the-art precision in dose control to give cancer patients the best possible outcomes. |
|
Read More ...
|
|
| |
May 28, 2009
Elekta delivers 3D Brain Mapping Technology to leading German brain research center
|
|
The University Hospital at Heinrich-Heine-University (HHU, Düsseldorf, Germany) has installed Elekta Neuromag®, a device for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology. Completely non-invasive and painless, MEG is a powerful tool used for studying normal brain function, as well as brain disorders, such as epilepsy and autism. |
|
Read More ...
|
|
| |
May 27, 2009
Elekta and The Ottawa Hospital forge long-term strategic partnership agreement
|
|
Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support project that will create an advanced cancer treatment centre. Part of The Ottawa Hospital, The Ottawa Hospital Cancer Centre (TOHCC), will be equipped with radiation therapy systems, as well as workflow enhancing software and treatment planning systems, enabling TOHCC to provide sophisticated therapeutic services in a chartless, paperless clinical environment. |
|
Read More ...
|
|
| |
May 18, 2009
Elekta and Nucletron combine forces to market leading software
|
|
Elekta and Nucletron have reached an agreement to market and license Elekta’s software system MOSAIQ®. Nucletron’s existing Oncentra® Visir and Oncentra® Information Management customers will be offered a high-quality solution with excellent future prospects of continued innovation from the world’s largest supplier of oncology software. |
|
Read More ...
|
|
| |
May 11, 2009
U.K. Cancer Centre Begins Innovative Radiotherapy Treatment With Four Elekta Systems
|
|
Velindre Cancer Centre (Cardiff, Wales, U.K.) has awarded Elekta with a multiple Elekta Synergy® order, bringing the department’s installation to four. All four systems will be used to facilitate Volumetric Modulated Arc Therapy (VMAT), a treatment technique that offers shorter treatment times while providing more precise control of the radiation dose to maximize safety to nearby normal tissues. This latest order will see the replacement of existing third party vendor equipment together with implementing MOSAIQ® as the sole patient information system. |
|
Read More ...
|
|
| |
September 12, 2008
Elekta Announces Availability of ERGO++ For VMAT Treatment Planning
|
|
Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, today announced, the clinical release of ERGO++ 1.7.1. for Volumetric Modulated Arc Therapy (VMAT), a new treatment technique offering shorter treatment times with the highest degree of precision. Building upon the experience of Arc Modulation, ERGO++ for VMAT can be used with a wide range of equipment, including mini and micro MLCs in addition to the Elekta MLCi (10mm) and Beam Modulator (4mm, full interdigitation).
|
|
Read More ...
|
|
| |
September 9, 2008
The Canadian Association of Radiation Oncology and Elekta Award Research Fellowship
|
|
Radiation oncology and medical technology groups award the second annual
CARO-Elekta Research Fellowship to Dr. Scott Carlyle Morgan
Vancouver, BC – The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2008 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. Scott Carlyle Morgan. The $75,000 fellowship, provided by Elekta, will enable Dr. Morgan to conduct research with the Uro-Oncology Unit at the Royal Marsden Hospital in London, England with Professor David Dearnaley. His research will revolve around a newly emerging approach to treating prostate cancer that involves the delivery of very precise radiation treatment only to regions of the prostate gland that harbour cancer. He is scheduled to begin his research in November 2008.
|
|
Read More ...
|
|
| |
August 29, 2008
CMS, Inc., An Elekta Company, Announces First Cancer Patients Treated with Monaco™ Radiation Treatment Planning System
|
|
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application. |
|
Read More ...
|
|
| |
July 25, 2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
|
|
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency.
|
|
Read More ...
|
|
|